COVID-19 Impact on cancer patients | Abstract

Journal of Research in Medical and Dental Science
eISSN No. 2347-2367 pISSN No. 2347-2545

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

COVID-19 Impact on cancer patients

Author(s): Surabhi* and Sonali Choudhari


Background: The coronavirus disease 2019 (COVID-19) has spread fast over the world, prompting the proclamation of a pandemic. As the pandemic evolves, scientists are learning more about the virus and how it affects us. According to early studies, elderly patients with various chronic health conditions, such as hypertension, diabetes, and obesity, were more likely to develop severe COVID-19 after contracting SARS-CoV-2. According to growing data, patients with cancer have been demonstrated to be a particularly vulnerable group. Cancer patients have a weaker immune system as a result of traits particular to the development of cancer or even treatment, making them more liable to COVID-19 infections. Due to heightened immunosuppression, patients with haematological malignancies and those having aggressive chemotherapy treatment may be at the greatest risk. As a cancer patient contracts COVID-19, the risk of organ-related problems increases when compared to a healthy person. The establishment of protective strategies should be encouraged for cancer patients, thereby decreasing their exposure to the SARS-CoV-2 virus and thus helping to maintain the public's health. Objective:The objective is to review the article related to COVID-19 and cancer. Methodology: For the review article, we gathered the data from various databases like PubMed, ScienceDirect, Google, and other websites involving searches for cancer, COVID-19, risk factors, and chemotherapy. Result: After reviewing the article, complications and mortality were higher in comparison to cancer free patients. Conclusion: After reviewing the article, we conclude that cancer patients are more vulnerable to COVID-19 and as a risk factor leads to more complications and greater mortality.

Share this article